patentgrepDocs Get an API key

C07D 519/02

Ergot alkaloids of the cyclic peptide type

C07D519/02 (Ergot alkaloids of the cyclic peptide type) appears on 42 US grants and 25 published applications in this corpus.

Search patents in C07D

Granted patents: 42
Published applications: 25
Assignees: 20
Inventors: 110
Latest grant: 8 Apr 2025

Filings by year

C07D 519/02: granted patents and published applications per publication year
Year	Granted patents	Published applications
1978	4	0
1979	0	0
1980	6	0
1981	1	0
1982	0	0
1983	2	0
1984	1	0
1985	2	0
1986	2	0
1987	2	0
1988	1	0
1989	2	0
1990	1	0
1991	0	0
1992	0	0
1993	0	0
1994	0	0
1995	0	0
1996	0	0
1997	0	0
1998	0	0
1999	0	0
2000	0	0
2001	0	0
2002	0	0
2003	0	0
2004	0	1
2005	0	1
2006	0	2
2007	0	1
2008	2	0
2009	1	0
2010	0	0
2011	0	1
2012	0	1
2013	2	1
2014	3	7
2015	4	2
2016	1	4
2017	3	0
2018	0	1
2019	1	0
2020	0	0
2021	0	1
2022	0	0
2023	0	0
2024	0	0
2025	1	2

By publication year. Applications have been published since 2001.

Recent patents

Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
Condensed cyclic compound and organic light emitting device including the same23 Jul 2019US 10,361,377 B2Samsung SDI.Co., Ltd.
Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,937 B2Theaprin Pharmaceuticals Inc.
Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,938 B2Theaprin Pharmaceuticals Inc.
Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,939 B2Theaprin Pharmaceuticals Inc.

Most cited

By later US patents